Role of Selective Autophagy of Focal Adhesion in Intracranial Aneurysm
局部粘连选择性自噬在颅内动脉瘤中的作用
基本信息
- 批准号:10586692
- 负责人:
- 金额:$ 38.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-15 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAffinityAnimal ModelAreaAutophagocytosisBindingBiological AssayBlood VesselsBrain AneurysmsCause of DeathCellsCessation of lifeCircle of WillisComplexDataDegradation PathwayDevelopmentDigestionDiseaseEndothelial CellsEndotheliumExhibitsExtracellular MatrixFocal AdhesionsGenesGeneticGoalsGrowthHealthHospital CostsImpairmentIncidenceIntracranial AneurysmKineticsKnockout MiceKnowledgeLifeLinkMediatingMissionMolecularMorphologyMusNamesOperative Surgical ProceduresPathogenesisPathogenicityPathologicPathologyPharmacological TreatmentPhosphorylationPlayProcessPublic HealthResearchResolutionRoleRuptureRuptured AneurysmSeriesStainsStrokeSubarachnoid HemorrhageSurgical ClipsSystemTestingTimeUnited States National Institutes of HealthVariantVascular PermeabilitiesWorkZebrafishburden of illnesscerebral arterycerebrovasculardisabilityexperimental studygain of functionimprovedinnovationknock-downmouse modelnew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticspreservationpreventreceptorreceptor bindingshear stresssingle moleculestroke patientsuperresolution microscopytherapeutic targetvasodilator-stimulated phosphoprotein
项目摘要
PROJECT SUMMARY
An intracranial aneurysm (IA) is a bulge or ballooning of the cerebral artery due to weakness in the blood
vessel wall. IA rupture causes subarachnoid hemorrhage (SAH), the most life-threatening form of stroke.
However, the molecular mechanisms underlying IA pathogenesis are poorly understood, which greatly
impedes the identification of therapeutic targets. To date, no pharmacological treatment is available for
IA except for invasive surgical options, such as surgical clipping and endovascular coiling, both of which
are generally associated with high hospitalization costs. Our long-term goal is to elucidate the molecular
mechanisms of IA and develop new therapeutic avenues for this devastating disease. The overall
objective in this application is to determine the role of selective autophagy of endothelial focal adhesion
(FA) in cerebrovascular integrity and IA formation and progression. The central hypothesis is that p62-
VASP interaction is a critical cargo recognition mechanism for selective autophagy of FA (FA-phagy) in
endothelial cells, which impairs cerebrovascular integrity and contributes to IA formation and progression.
The central hypothesis will be tested in two specific aims: 1) dissect the molecular mechanisms of FA-
phagy in endothelial cells; and 2) determine the role of endothelial FA-phagy in cerebrovascular integrity
and IA formation and progression. Our proposal is innovative, because we are the first to identify p62-
VASP interaction as a novel cargo recognition mechanism for endothelial FA-phagy, and provide
endothelial FA-phagy as a novel pathogenic mechanism for IA. The proposed research is significant
because we connect selective autophagy to cerebrovascular integrity, which will not only add cutting-
edge knowledge to the selective autophagy field but also provide anti-FA-phagy strategy as a novel
therapy for IA disease or potentially for many other diseases that exhibit the loss of vascular integrity.
项目摘要
颅内动脉瘤(IA)是由于血液无力而导致大脑动脉的隆起或膨胀
船墙。 IA破裂会导致蛛网膜下腔出血(SAH),这是中风的生命最长的形式。
然而,IA发病机理的分子机制知之甚少,这是广泛的
阻碍了治疗靶标的识别。迄今为止,尚无药理学治疗
ia除了侵入性手术选择,例如手术剪裁和血管内卷曲,这两个
通常与高住院费用有关。我们的长期目标是阐明分子
IA的机制并为这种毁灭性疾病开发新的治疗途径。总体
本应用程序中的目的是确定内皮局灶性粘附选择性自噬的作用
(FA)在脑血管完整性和IA形成和进展中。中心假设是p62-
VASP相互作用是FA选择性自噬(FA-Phagy)的关键货物识别机制
内皮细胞会损害脑血管完整性,并有助于IA的形成和进展。
中央假设将以两个具体的目的进行检验:1)剖析FA-的分子机制
内皮细胞中的吞噬; 2)确定内皮FA-Phagy在脑血管完整性中的作用
和IA的形成和进展。我们的建议是创新的,因为我们是第一个确定p62-的人
VASP相互作用是一种新型货物识别机制,用于内皮FA-PHAGY,并提供
内皮FA-Phagy是IA的新型致病机制。拟议的研究很重要
因为我们将选择性自噬连接到脑血管完整性,这不仅会增加剪切 -
在选择性自噬领域的边缘知识,但也提供了反粉刺策略作为一种新颖的策略
IA疾病的治疗或许多其他表现出血管完整性丧失的疾病的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yanning Rui其他文献
Yanning Rui的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yanning Rui', 18)}}的其他基金
Role of p62-Mediated Endothelial FA-Phagy in Intracranial Aneurysms
p62 介导的内皮 FA 吞噬在颅内动脉瘤中的作用
- 批准号:
10574825 - 财政年份:2023
- 资助金额:
$ 38.21万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 38.21万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 38.21万 - 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
- 批准号:
10601679 - 财政年份:2023
- 资助金额:
$ 38.21万 - 项目类别:
PPARdelta receptors and alcohol use phenotypes
PPARδ 受体和饮酒表型
- 批准号:
10682348 - 财政年份:2023
- 资助金额:
$ 38.21万 - 项目类别: